DE2748520A1 - Hepatitis b-dane-teilchen - Google Patents

Hepatitis b-dane-teilchen

Info

Publication number
DE2748520A1
DE2748520A1 DE19772748520 DE2748520A DE2748520A1 DE 2748520 A1 DE2748520 A1 DE 2748520A1 DE 19772748520 DE19772748520 DE 19772748520 DE 2748520 A DE2748520 A DE 2748520A DE 2748520 A1 DE2748520 A1 DE 2748520A1
Authority
DE
Germany
Prior art keywords
density gradient
dane particles
gradient
sodium bromide
dane
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19772748520
Other languages
German (de)
English (en)
Other versions
DE2748520C2 (fr
Inventor
William Joseph Mcaleer
Edward Henry Wasmuth
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US05/784,191 external-priority patent/US4129646A/en
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of DE2748520A1 publication Critical patent/DE2748520A1/de
Application granted granted Critical
Publication of DE2748520C2 publication Critical patent/DE2748520C2/de
Granted legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D43/00—Separating particles from liquids, or liquids from solids, otherwise than by sedimentation or filtration
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
DE19772748520 1976-11-02 1977-10-28 Hepatitis b-dane-teilchen Granted DE2748520A1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US73786276A 1976-11-02 1976-11-02
US05/784,191 US4129646A (en) 1976-11-02 1977-04-04 Isolating hepatitis B Dane particles

Publications (2)

Publication Number Publication Date
DE2748520A1 true DE2748520A1 (de) 1978-05-03
DE2748520C2 DE2748520C2 (fr) 1987-07-30

Family

ID=27113269

Family Applications (1)

Application Number Title Priority Date Filing Date
DE19772748520 Granted DE2748520A1 (de) 1976-11-02 1977-10-28 Hepatitis b-dane-teilchen

Country Status (5)

Country Link
JP (1) JPS5379011A (fr)
DE (1) DE2748520A1 (fr)
FR (3) FR2394297A1 (fr)
GB (2) GB1554399A (fr)
NL (1) NL7711378A (fr)

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816864A1 (de) * 1977-04-20 1978-10-26 Merck & Co Inc Hepatitis b-kern-antigen
DE3049690A1 (de) * 1979-07-05 1982-02-18 Alpha Therapeutic Corp Process for producing hepatitis b vaccine
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
EP0114291A2 (fr) * 1983-01-24 1984-08-01 Bodo Dr. Plewinsky Milieu pour la séparation de matières dissoutes et/ou en suspension en fonction de leurs flottabilités ou de leurs densités différentes, au moyen de solutions de métatungstates purs

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK366778A (da) * 1978-08-18 1980-02-19 Foss Electric As Fremgangsmaade til taelling af bakterier
FR2561256B1 (fr) * 1984-03-16 1987-01-02 Pasteur Institut Procede de purification de particules biologiques de type antigene hbs, par ultracentrifugation de flottation sur gradient de densite

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1356413A (en) * 1971-09-09 1974-06-12 Pfizer Ltd Method of obtaining purified australia antigen from blood serum
US4029764A (en) * 1974-12-09 1977-06-14 Merck & Co., Inc. Hepatitis A antigen
US4024243A (en) * 1975-06-16 1977-05-17 Merck & Co., Inc. Process for isolating hepatitis B antigen
GB1554811A (en) * 1977-02-23 1979-10-31 Merck & Co Inc Purifying hepatitis b surface antigen
FR2412315A1 (fr) * 1977-02-23 1979-07-20 Merck & Co Inc Procede de preparation d'un antigene de l'hepatite b et l'antigene obtenu

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NICHTS-ERMITTELT *

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2816864A1 (de) * 1977-04-20 1978-10-26 Merck & Co Inc Hepatitis b-kern-antigen
DE3049690A1 (de) * 1979-07-05 1982-02-18 Alpha Therapeutic Corp Process for producing hepatitis b vaccine
DE3150935A1 (de) * 1981-12-23 1983-06-30 Uwe Dr.med. 3400 Göttingen Böttcher Verfahren zur herstellung eines hepatitis-b impfstoffes
EP0114291A2 (fr) * 1983-01-24 1984-08-01 Bodo Dr. Plewinsky Milieu pour la séparation de matières dissoutes et/ou en suspension en fonction de leurs flottabilités ou de leurs densités différentes, au moyen de solutions de métatungstates purs
EP0114291A3 (fr) * 1983-01-24 1985-12-04 Bodo Dr. Plewinsky Milieu pour la séparation de matières dissoutes et/ou en suspension en fonction de leurs flottabilités ou de leurs densités différentes, au moyen de solutions de métatungstates purs

Also Published As

Publication number Publication date
GB1554399A (en) 1979-10-17
DE2748520C2 (fr) 1987-07-30
NL7711378A (nl) 1978-05-05
FR2422406B1 (fr) 1982-11-19
GB1554400A (en) 1979-10-17
JPS5379011A (en) 1978-07-13
FR2422406A1 (fr) 1979-11-09
FR2422399B1 (fr) 1982-11-19
FR2394297A1 (fr) 1979-01-12
JPS635381B2 (fr) 1988-02-03
FR2422399A1 (fr) 1979-11-09
FR2394297B1 (fr) 1982-11-19

Similar Documents

Publication Publication Date Title
DE2707881C2 (de) Verfahren zum Nachweis von rheumatoiden Faktoren
DE2801123A1 (de) Verfahren zur herstellung eines intravenoes applizierbaren serumeiweiss- praeparates
CH627187A5 (fr)
DE2624815B2 (de) Herstellung einer injizierbaren, stromafreien und von Plasmaproteinen freien Hämoglobinlösung
DE2500076A1 (de) Verfahren zur erhoehung der intravenoesvertraeglichkeit von aus blut oder blutprodukten ausgefaellten gammaglobulinen
DE2403994A1 (de) Herstellung von antisera
DE2748520A1 (de) Hepatitis b-dane-teilchen
DE3105555C2 (fr)
DE2850950C3 (de) Verwendung von nativem oder thermisch modifiziertem Cytochrom c als Stabilisator für ein immunochemisches Meßreagens, immunochemisches Meßreagens sowie Pufferlösung zur Probenverdünnung bei immunchemischen Meßverfahren
DE2658170A1 (de) Arzneimittel zur behandlung der durch den hepatitisvirus b ausgeloesten akuten oder chronischen infektionen
DE2551576C3 (de) Träger für immunochemische Messungen
DE2616984A1 (de) Verfahren zur anreicherung eines plazentenspezifischen glycoproteins
DE2707913C2 (de) Verfahren zum Nachweis von rheumatoiden Faktoren
DE2025718C3 (de) Verfahren zum Stabilisieren von lyophillsierten Erythrozyten
DE2515666C3 (de) Piasminreiche Gammaglobulinfraktion, Verfahren zu deren Herstellung und das Verfahrensprodukt enthaltendes Gammaglobulinpräparat
DE2235600C3 (de) Verfahren zur Reinigung von Γ-Globulin
DE3039855A1 (de) Verfahren zur abtrennung von (beta)-globulinaggregat mittels membran
DE3028977A1 (de) Verfahren zur ausstellung von antikoerperserum mit erhoehter agglutinationsaktivitaet
DE2440926C3 (de) Injizierbarer inaktivierter Impfstoff gegen Hepatitis B und Verfahren zu seiner Herstellung
DE2243237A1 (de) Nachweis der immunreaktion gegenueber krebs
DE1598859C (de) Verfahren zur Herstellung von Reagen zien für immunochemische Bestimmungen
DE2353035A1 (de) Verfahren zur stabilisierung menschlicher oder tierischer koerperfluessigkeiten oder pflanzlicher extrakte
DE2062558A1 (de) Mittel zur Diagnose von primärem Leberkrebs und Verfahren zur Her stellung desselben
DE2533183C3 (de) Verfahren zum Herstellen gereinigter Immunglobuline
DE2602892A1 (de) Konzentriertes hepatitis-b-oberflaechenantigen enthaltende masse und verfahren zu ihrer herstellung

Legal Events

Date Code Title Description
8110 Request for examination paragraph 44
D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee